CD19 and acute lymphoblastic leukemia: Besides studies indicating that only cells with a primitive phenotype are able to engraft B-ALL in NOD/SCID mice, several other studies found contradictory results showing that exclusively the more mature CD19+ B-ALL cells were capable of engrafting[152,153].